Literature DB >> 21324869

Oseltamivir-resistant pandemic H1N1 influenza.

Duncan Webster1, Yan Li, Nathalie Bastien, Richard Garceau, Todd F Hatchette.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21324869      PMCID： PMC3080559          DOI： 10.1503/cmaj.100313

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Oseltamivir resistance--disabling our influenza defenses.

Authors:  Anne Moscona
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

2.  Oseltamivir resistance during treatment of influenza A (H5N1) infection.

Authors:  Menno D de Jong; Tan Thanh Tran; Huu Khanh Truong; Minh Hien Vo; Gavin J D Smith; Vinh Chau Nguyen; Van Cam Bach; Tu Qui Phan; Quang Ha Do; Yi Guan; J S Malik Peiris; Tinh Hien Tran; Jeremy Farrar
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

3.  Oseltamivir resistance: what does it mean clinically?

Authors:  Stephen G Baum
Journal:  Clin Infect Dis       Date:  2009-12-15       Impact factor: 9.079

4.  Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.

Authors:  Mariana Baz; Yacine Abed; Jesse Papenburg; Xavier Bouhy; Marie-Eve Hamelin; Guy Boivin
Journal:  N Engl J Med       Date:  2009-11-11       Impact factor: 91.245
  4 in total
  4 in total

1.  High throughput screening for small molecule enhancers of the interferon signaling pathway to drive next-generation antiviral drug discovery.

Authors:  Dhara A Patel; Anand C Patel; William C Nolan; Yong Zhang; Michael J Holtzman
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

2.  Preventive Activity against Influenza (H1N1) Virus by Intranasally Delivered RNA-Hydrolyzing Antibody in Respiratory Epithelial Cells of Mice.

Authors:  Seungchan Cho; Ha-Na Youn; Phuong Mai Hoang; Sungrae Cho; Kee-Eun Kim; Eui-Joon Kil; Gunsup Lee; Mun-Ju Cho; Juhyun Hong; Sung-June Byun; Chang-Seon Song; Sukchan Lee
Journal:  Viruses       Date:  2015-09-21       Impact factor: 5.048

3.  Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine.

Authors:  Hadi Ghaffari; Ahmad Tavakoli; Abdolvahab Moradi; Alijan Tabarraei; Farah Bokharaei-Salim; Masoumeh Zahmatkeshan; Mohammad Farahmand; Davod Javanmard; Seyed Jalal Kiani; Maryam Esghaei; Vahid Pirhajati-Mahabadi; Seyed Hamidreza Monavari; Angila Ataei-Pirkooh
Journal:  J Biomed Sci       Date:  2019-09-10       Impact factor: 8.410

Review 4.  Identification of Potential Drug Targets of Broad-Spectrum Inhibitors with a Michael Acceptor Moiety Using Shotgun Proteomics.

Authors:  Hao-Wei Chu; Bidyadhar Sethy; Pei-Wen Hsieh; Jim-Tong Horng
Journal:  Viruses       Date:  2021-09-02       Impact factor: 5.048
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.